build a site

Antibody-Dependent Cellular Cytotoxicity (ADCC)

There’s a BIOENSIS solution for each of your predictive pharmacology challenges

Explore BIOENSIS 3D Immuno-oncology platform to evaluate your biological samples. Our unique 3D antibody-dependent cellular cytotoxicity (ADCC) and retargeted T cell cytotoxicity platforms enable efficacy evaluation of therapeutic antibodies in 2D/3D cultures. 

Key assay features:

• Over 150 target tumor cell lines available for testing
• PBMC's, NK's and T cells available for testing
• Models tested in high-throughput format
• Precision EC50 results
• Flexible testing protocols including single and combination agents
• Available in 2D and 3D cultures 

Please contact us to discuss your study needs and an up to date list of available cell lines   

Don’t see it here? BIOENSIS has the expertise and flexibility to develop custom assays designed to answer your critical pharmacology questions.

Quick Inquiry


19201 120TH AV NE, Suite 107
Bothell, WA 98011


Phone: 425-246-6040